45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
17,456
Insurances with rates
15
CPT / HCPCS codes
12,687
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION | $88,333 | $70,666 | — | — | 32 |
| C1874 | HB OR-IMPL AORTIC ENDOPROSTH THOR (43) | $72,103 | $57,683 | — | — | 32 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $53,337 | $42,669 | — | — | 32 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $48,058 | $38,447 | — | — | 26 |
| C1786 | HB OR-IMPL PACEMAKER (36) | $44,063 | $35,250 | — | — | 32 |
| J2997 | ALTEPLASE 100 MG INTRAVENOUS SOLUTION | $38,326 | $30,661 | — | — | 32 |
| C1767 | HB OR-IMPL PAIN GEN/STIMULATOR (33) | $36,052 | $28,841 | — | — | 26 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $35,203 | $28,162 | — | — | 32 |
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $33,431 | $26,745 | — | — | 32 |
| J9325 | TALIMOGENE LAHERPAREPVEC 10EXP8 (100 MILLION)PFU/ML SUSP FOR INJECTION | $33,319 | $26,655 | — | — | 43 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $28,548 | $22,838 | — | — | 26 |
| J9272 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $27,461 | $21,969 | — | — | 26 |
| J9144 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN | $24,491 | $19,593 | — | — | 26 |
| 0278 | HB OR-IMPL BONE MATRIX (25) | $20,029 | $16,023 | — | — | 43 |
| C1771 | HB OR-IMPL SLING GRAFT (25) | $20,029 | $16,023 | — | — | 32 |
| J2323 | NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION | $19,978 | $15,983 | — | — | 32 |
| J2353 | OCTREOTIDE,MICROSPHERES ER 20 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE | $19,501 | $15,601 | — | — | 32 |
| J9312 | RITUXIMAB 10 MG/ML CONCENTRATE,INTRAVENOUS | $18,951 | $15,161 | — | — | 32 |
| J9299 | NIVOLUMAB 240 MG/24 ML INTRAVENOUS SOLUTION | $18,131 | $14,505 | — | — | 32 |
| J9271 | PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION | $17,781 | $14,225 | — | — | 32 |
| J3101 | TENECTEPLASE 50 MG INTRAVENOUS SOLUTION (FOR STEMI) | $17,726 | $14,181 | — | — | 32 |
| J0517 | BENRALIZUMAB 30 MG/ML SUBCUTANEOUS AUTO-INJECTOR | $17,628 | $14,102 | — | — | 38 |
| J9352 | TRABECTEDIN 1 MG INTRAVENOUS SOLUTION | $17,510 | $14,008 | — | — | 32 |
| J9307 | PRALATREXATE 20 MG/ML (1 ML) INTRAVENOUS SOLUTION | $17,252 | $13,802 | — | — | 38 |
| C1768 | HB OR-IMPL PERIPH VASCULAR GRAFT (23) | $16,023 | $12,818 | — | — | 32 |
| J9306 | PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION | $15,880 | $12,704 | — | — | 43 |
| J1303 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION | $15,285 | $12,228 | — | — | 32 |
| J9204 | MOGAMULIZUMAB-KPKC 4 MG/ML INTRAVENOUS SOLUTION | $14,207 | $11,365 | — | — | 26 |
| J9330 | TEMSIROLIMUS 30 MG/3 ML (10 MG/ML) (FIRST DILUTION) INTRAVENOUS SOLN | $13,578 | $10,863 | — | — | 26 |
| J9354 | ADO-TRASTUZUMAB EMTANSINE 100 MG INTRAVENOUS SOLUTION | $12,028 | $9,623 | — | — | 20 |
| J9356 | TRASTUZUMAB 600 MG-HYALURONIDASE-OYSK 10,000 UNIT/5 ML SUBCUT SOLUTION | $11,981 | $9,585 | — | — | 32 |
| Q5127 | PEGFILGRASTIM-FPGK 6 MG/0.6 ML SUBCUTANEOUS SYRINGE | $11,777 | $9,422 | — | — | 20 |
| J9305 | PEMETREXED DISODIUM 500 MG INTRAVENOUS POWDER FOR SOLUTION | $11,185 | $8,948 | — | — | 26 |
| Q5120 | PEGFILGRASTIM-BMEZ 6 MG/0.6 ML SUBCUTANEOUS SYRINGE | $10,978 | $8,783 | — | — | 43 |
| Q5107 | BEVACIZUMAB-AWWB 25 MG/ML INTRAVENOUS SOLUTION | $10,939 | $8,751 | — | — | 64 |
| J9047 | CARFILZOMIB 60 MG INTRAVENOUS SOLUTION | $10,663 | $8,530 | — | — | 32 |
| C1874 | HB OR-IMPL VASC STENT (19) | $10,633 | $8,506 | — | — | 43 |
| C1877 | HB OR-IMPL VASC STENT NONCOAT (19) | $10,633 | $8,506 | — | — | 38 |
| Q5146 | TRASTUZUMAB-STRF 420 MG INTRAVENOUS SOLUTION | $10,488 | $8,390 | — | — | 32 |
| Q5111 | PEGFILGRASTIM-CBQV 6 MG/0.6 ML (DELIVERABLE) WEARABLE SUBCUT INJECTOR | $10,247 | $8,198 | — | — | 32 |
| Q5111 | PEGFILGRASTIM-CBQV 6 MG/0.6 ML SUBCUTANEOUS SYRINGE | $9,818 | $7,854 | — | — | 38 |
| J9319 | ROMIDEPSIN 10 MG/2 ML INTRAVENOUS POWDER FOR SOLUTION | $9,643 | $7,715 | — | — | 20 |
| J9034 | BENDAMUSTINE 25 MG/ML INTRAVENOUS SOLUTION | $9,481 | $7,585 | — | — | 43 |
| J2182 | MEPOLIZUMAB 100 MG SUBCUTANEOUS SOLUTION | $9,211 | $7,369 | — | — | 38 |
| 26951 | HB AMPUTATION FNGR/THUMB W/ DIR CLSE | $9,170 | $7,336 | — | — | 20 |
| L8612 | HB OR-IMPL OPTHALMIC SHUNT (17) | $9,116 | $7,293 | — | — | 26 |
| J0897 | DENOSUMAB 120 MG/1.7 ML (70 MG/ML) SUBCUTANEOUS SOLUTION | $9,066 | $7,253 | — | — | 32 |
| 78492 | HB RADIANT MYO PERF MULT-REST/STRESS (PET) | $9,007 | $7,206 | — | — | 32 |
| J9205 | IRINOTECAN LIPOSOMAL 4.3 MG/ML INTRAVENOUS | $8,981 | $7,185 | — | — | 32 |
| Q5136 | DENOSUMAB-BBDZ 120 MG/1.7 ML (70 MG/ML) SUBCUTANEOUS SOLUTION | $8,875 | $7,100 | — | — | 32 |
Showing top 50 of 17,456 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.